In vitro modelling of human tumour behaviour in drug discovery programmes
Open Access
- 30 April 2004
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (6) , 794-801
- https://doi.org/10.1016/j.ejca.2003.12.019
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Update on NCI in vitro drug screen utilitiesEuropean Journal Of Cancer, 2004
- Modelling cell death in human tumour cell lines exposed to the anticancer drug paclitaxelJournal of Mathematical Biology, 2004
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1996
- Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screenDrug Development Research, 1995
- Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancerEuropean Journal Of Cancer, 1995
- Microculture-Based Chemosensitivity Testing: A Feasibility Study Comparing Freshly Explanted Human Melanoma Cells With Human Melanoma Cell LinesJNCI Journal of the National Cancer Institute, 1992
- A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cellsAnalytical Biochemistry, 1984
- Current results of the screening program at the division of cancer treatment, national cancer institutePublished by Elsevier ,1981
- Primary Bioassay of Human Tumor Stem CellsScience, 1977